Visit COVID-19 resources

[Skip to Content]

Eye Journal

Comment on ‘Topiramate maculopathy secondary to dose titration: first reported case’ – (Eye Journal AOP)

Oct 16
2015

Comment on ‘Topiramate maculopathy secondary to dose titration: first reported case’ Eye advance online publication, October 16 2015. doi:10.1038/eye.2015.194 Authors: P Kozner, S K Wagner, B Brozek & S Althauser

  • 16 October 2015

Reply: ‘The accuracy of the Edinburgh Red Eye Diagnostic Algorithm’ – (Eye Journal AOP)

Oct 16
2015

Reply: ‘The accuracy of the Edinburgh Red Eye Diagnostic Algorithm’ Eye advance online publication, October 16 2015. doi:10.1038/eye.2015.195 Authors: H Timlin, L Butler & M Wright

  • 16 October 2015

Response to ‘Comment on Topiramate maculopathy secondary to dose titration: first reported case’ – (Eye Journal AOP)

Oct 16
2015

Response to ‘Comment on Topiramate maculopathy secondary to dose titration: first reported case’ Eye advance online publication, October 16 2015. doi:10.1038/eye.2015.196 Authors: R J Symes, P S Severn, R Rajendram & B Pal

  • 16 October 2015

The ocular phenotype of stiff-skin syndrome – (Eye Journal AOP)

Oct 16
2015

The ocular phenotype of stiff-skin syndrome Eye advance online publication, October 16 2015. doi:10.1038/eye.2015.183 Authors: S Chamney, B Cartmill, O Earley, V McConnell & C E Willoughby

  • 16 October 2015

The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease – (Eye Journal AOP)

Oct 09
2015

The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease Eye advance online publication, October 9 2015. doi:10.1038/eye.2015.170 Authors: J Taylor, L J Scott, C A Rogers, A Muldrew, D O’Reilly, S Wordsworth, N Mills, R Hogg,

  • 9 October 2015